Skip to content

Studies on microparticles and DIC in patients with pancreatitis

Studies on microparticles and DIC in patients with pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015169
Enrollment
Unknown
Registered
2018-03-12
Start date
2018-03-12
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatitis

Interventions

experimental group:none
Control group:Nil

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with acute pancreatitis treated by ICU in The First Affiliated Hospital of Harbin Medical University are in line with the guidelines for diagnosis and revision of acute pancreatitis in 2012; 2. The patient meets the ISTH DIC diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. End-stage heart diseas; 2. Long-term chronic kidney disease, end-stage liver disease; 3. Aged < 18 years ol; 4. To pregnant, pregnant or lactating wome; 5. Long-term use of aspirin and other vasoactive drugs.

Design outcomes

Primary

MeasureTime frame
microparticle phenotype and distribution;serum amylase;

Countries

China

Contacts

Public ContactXue Dongbo

The First Affiliated Hospital of Harbin Medical University

xue9971@sina.com+86 13845103698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026